| 1 | NBIX | Neurocrine Biosciences, Inc. | 4.18% |
| 2 | EXAS | Exact Sciences Corporation | 3.86% |
| 3 | ACAD | ACADIA Pharmaceuticals Inc. | 3.75% |
| 4 | ALKS | Alkermes plc | 3.64% |
| 5 | HALO | Halozyme Therapeutics, Inc. | 3.64% |
| 6 | NTRA | Natera, Inc. | 3.55% |
| 7 | UTHR | United Therapeutics Corporation | 3.54% |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.51% |
| 9 | WAT | Waters Corporation | 3.49% |
| 10 | ILMN | Illumina, Inc. | 3.44% |
| 11 | MTD | Mettler-Toledo International Inc. | 3.42% |
| 12 | BMRN | BioMarin Pharmaceutical Inc. | 3.40% |
| 13 | INCY | Incyte Corporation | 3.40% |
| 14 | BRKR | Bruker Corporation | 3.38% |
| 15 | RGEN | Repligen Corporation | 3.36% |
| 16 | CORT | Corcept Therapeutics Incorporated | 3.36% |
| 17 | EXEL | Exelixis, Inc. | 3.34% |
| 18 | GMAB | Genmab A/S | 3.34% |
| 19 | BIIB | Biogen Inc. | 3.32% |
| 20 | ONC | BeiGene, Ltd. | 3.31% |
| 21 | REGN | Regeneron Pharmaceuticals, Inc. | 3.19% |
| 22 | BNTX | BioNTech SE | 3.17% |
| 23 | VCYT | Veracyte, Inc. | 3.17% |
| 24 | ARGX | argenx SE | 3.17% |
| 25 | AMGN | Amgen Inc. | 3.08% |
| View FBT holdings |